Reversal of protein aggregation provides evidence for multiple aggregated states

被引:72
作者
Calamai, M
Canale, C
Relini, A
Stefani, M
Chiti, F
Dobson, CM
机构
[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[2] Univ Genoa, Dipartimento Fis, I-16146 Genoa, Italy
[3] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
基金
英国惠康基金;
关键词
amyloid; disaggregation kinetics; stability; refolding; size;
D O I
10.1016/j.jmb.2004.11.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Observations that prefibrillar aggregates from different amyloidogenic proteins can be solubilised under some conditions have raised questions as to the generality of this phenomenon and the nature of the factors that influence it. By studying aggregates formed from human muscle acylphosphatase (AcP) under mild denaturing conditions, and by using a battery of techniques, we demonstrate that disaggregation is possible under conditions close to physiological where the protein is stable in its native state. In the presence of 25% (v/v) trifluoroethanol (TFE) AcP undergoes partial unfolding and globular aggregates (60-200 nm in diameter) that can assemble further into clusters (400-800 nm in diameter) develop progressively. Yet larger superstructures (> 5 mum) are formed when the concentration of the globular aggregates exceeds a critical concentration. After diluting the sample to give a solution containing 5% TFE, the fraction of partially unfolded monomeric protein refolds very rapidly, with a rate constant of similar to 1 s(-1). The 60-200 nm globular aggregates disaggregate with an apparent rate constant of similar to 2.5 x 10(-3) s(-1) while the 400-800 run clusters disassembly more slowly with a rate constant of similar to 3.1 x 10(-4) s(-1). The larger (> 5 mum) superstructures are not disrupted under the conditions used here. These results suggest that amyloid formation occurs in discrete steps whose reversibility is increasingly difficult, and dependent on the size of the aggregates, and that disaggregation experiments can provide a powerful method of detecting different types of species within the complex process of aggregation. In addition, our work suggests that destabilization of amyloid aggregates resulting in the conversion of misfolded proteins back to their native states could be an important factor in both the onset and treatment of diseases associated with protein aggregation. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:603 / 616
页数:14
相关论文
共 67 条
[1]   Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy [J].
Benveniste, H ;
Einstein, G ;
Kim, KR ;
Hulette, C ;
Johnson, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :14079-14084
[2]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[3]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[4]   Construction and deconstruction of bacterial inclusion bodies [J].
Carrió, MM ;
Villaverde, A .
JOURNAL OF BIOTECHNOLOGY, 2002, 96 (01) :3-12
[5]   Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[6]   Ligand-dependent inhibition and reversal of tau filament formation [J].
Chirita, C ;
Necula, M ;
Kuret, J .
BIOCHEMISTRY, 2004, 43 (10) :2879-2887
[7]   Development of enzymatic activity during protein folding - Detection of a spectroscopically silent native-like intermediate of muscle acylphosphatase [J].
Chiti, F ;
Taddei, N ;
Giannoni, E ;
van Nuland, NAJ ;
Ramponi, G ;
Dobson, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20151-20158
[8]   Designing conditions for in vitro formation of amyloid protofilaments and fibrils [J].
Chiti, F ;
Webster, P ;
Taddei, N ;
Clark, A ;
Stefani, M ;
Ramponi, G ;
Dobson, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3590-3594
[9]  
Chiti F, 1999, NAT STRUCT BIOL, V6, P380
[10]   Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases [J].
Chiti, F ;
Calamai, M ;
Taddei, N ;
Stefani, M ;
Ramponi, G ;
Dobson, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 :16419-16426